CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement for Book Closure and e-voting process for the Annual General Meeting31-08-2023
CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement for Book Closure and e-voting process for the Annual General MeetingCAPLIN POINT LABORATORIES LTD. - 524742 - Business Responsibility and Sustainability Reporting (BRSR)
Pursuant to Regulation 34(2)(f) of the SEBI Listing Regulations, 2015. We are submitting herewith the BRSR for FY 2022-23, which also forms part of the Annual Report for the FY 2022-23 submitted to the Exchanges vide letter dated August 30, 2023.CAPLIN POINT LABORATORIES LTD. - 524742 - Reg. 34 (1) Annual Report.
This is further to our letter dated August 7, 2023 wherein the Company had informed that the 32nd Annual General Meeting (AGM) of the Company is scheduled to be held on Thursday, September 21, 2023 through Video Conferencing / Other Audio-Visual Means, in accordance with the relevant circulars issued by Ministry of Corporate Affairs and Securities and Exchange Board of India (SEBI). In terms of the requirements of Regulation 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Annual Report of the Company, for the financial year 2022-23, which has been sent through electronic mode to the Members. The Annual Report has also been uploaded on the Company's website at https://www.caplinpoint.net/index.php/annual-report/ This is for your kind information and records.Caplin Point eyes doubling of US revenues from Q3
The companyaims to achieve the growth through strategic new product launches and by increasing market share for existing productsCAPLIN POINT LABORATORIES LTD. - 524742 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
This is to inform that the mentioned share certifcates has been reported as lost by the shareholders of the company.Caplin Point working on 550-crore capex expansion
Plans to expand existing capacities, add manufacturing sites to widen product range and achieve backward integration for a majority of productsCAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Change in Directorate
Appointment of Independent Director for further period subject to the approval of shareholders.Caplin Point secures spot on Forbes list of 200 Best Under a Billion'
The chosen 200 enterprises share a common characteristic of maintaining annual sales under $1 billion.